e-learning
resources
Virtual 2021
06.09.2021
Inhaled treatments for COPD: real-world data
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
No impact of statins on time to first COPD exacerbation or all-cause mortality
N. Godtfredsen (Hvidovre, Denmark), M. Damkjær (Hvidovre, Denmark), K. Håkansson (Hvidovre, Denmark), T. Kallemose (Hvidovre, Denmark), C. Ulrik (Hvidovre, Denmark)
Source:
Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Session:
Inhaled treatments for COPD: real-world data
Session type:
E-poster
Number:
2407
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Godtfredsen (Hvidovre, Denmark), M. Damkjær (Hvidovre, Denmark), K. Håkansson (Hvidovre, Denmark), T. Kallemose (Hvidovre, Denmark), C. Ulrik (Hvidovre, Denmark). No impact of statins on time to first COPD exacerbation or all-cause mortality. 2407
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
Predictors of mortality in COPD patients after hospitalization due to an exacerbation
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008
Tiotropium and the risk of cardiovascular events and all-cause mortality
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010
Trends in the lifetime risk of COPD exacerbation requiring hospitalisation
Source: Eur Respir J 2013; 42: 964-971
Year: 2013
Predictors of mortality in COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Predictors of mortality in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Predictors of mortality in COPD during acute exacerbation
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Statins and outcome of COPD patients after hospitalization for COPD exacerbations
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics
Source: Eur Respir J 2001; 17: 380-385
Year: 2001
Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Changes in physical activity and all-cause mortality in COPD
Source: Eur Respir J 2014; 44: 1199-1209
Year: 2014
Initial treatment and mortality in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 578s
Year: 2003
CAB score predicts short-term mortality at hospital admission for acute exacerbations of COPD
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017
Accelerated FEV
1
decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020
Year: 2021
Mortality predictors in COPD exacerbation
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Risk factors for mortality in patients with COPD exacerbation
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Evaluation of costs of inhospital treatment of COPD exacerbations
Source: Eur Respir J 2004; 24: Suppl. 48, 64s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept